Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Le Fevre
Do EU5 Countries With Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Testing Treatments: Better Research for Better Healthcare (2nd Edn)
Journal of Family Planning and Reproductive Health Care
Pnd92 - Access and Reimbursement for Current and Emerging Alzheimer’s Disease-Modifying Therapies in the Eu5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Countries With Better Health Systems Have Better Football Teams
BMJ
Psy137 - Orphan Drug Access and Reimbursement in the Eu5: Cystic Fibrosis and Duchenne Muscular Dystrophy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making
Health Policy
Large-Scale Computational Drug Repositioning to Find Treatments for Rare Diseases
npj Systems Biology and Applications
Genetics
Molecular Biology
Biochemistry
Applied Mathematics
Simulation
Computer Science Applications
Modeling
Drug Discovery
Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases: Health Professionals’ View in Serbia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
Frontiers in Pharmacology
Pharmacology
